Search

everythinglearnresearchcommunity

for

Search:↓

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Allopregnanolone changes gene expression in glioblastoma cells.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

The treatment combination is effective and generally safe for lung cancer.

MK-5108 is safe and shows potential against tumors, especially alone.

Both photobiomodulation and low-frequency treatments effectively reduce body measurements.

Baricitinib significantly regrows hair in severe alopecia areata patients.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Shock wave therapy improved muscle function and movement in children with spastic cerebral palsy.

Both fixed and incremental laser treatments effectively reduced underarm hair, but the fixed method was less painful.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Thermobalancing therapy is safe and effective for treating enlarged prostates.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Topical treatment SM04554 safely promotes hair growth in male baldness.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The combination treatment showed a higher response rate but no significant survival benefits.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.